Our remedy designed for defeating pathogens.
Introducing the New Standard of Care With the Synexis BioDefense System.
Infections caused by microbes like viruses and bacteria have always posed a major threat to healthcare systems. An estimated 99,000 patients die each year from healthcare-associated infections (HAIs)1, and it can cost hospitals anywhere between $28 billion and $45 billion.2
But Synexis can redefine how healthcare systems seek the reduction of microbes both in the air and on surfaces. Our DHP™ (Dry Hydrogen Peroxide) producing biodefense system continuously attacks viruses, bacteria, and odors along each step of the patient’s journey, from hectic ERs to outpatient clinics.
Our impressive DHP technology.
Synexis is the sole developer of the process by which naturally occurring oxygen and humidity are taken from the air to create Dry Hydrogen Peroxide (H2O2), otherwise known as DHP.
In the air and on surfaces: Where DHP flows.
Clinical Study Published in American Journal of Infection Control: Evaluation of DHP in Reducing Microbial Bioburden in a Healthcare Facility⁴
Sunrise Hospital, a 762-bed acute care facility in Las Vegas, NV, conducted a study evaluating the efficacy of DHP Technology on microbial air and surface contamination as an adjunct to routine cleaning and disinfection. Published in AJIC, the powerful results tell the tale all themselves.
DHP demonstrated a statistically significant 96.5% reduction in the average number of bacteria collected in all surface environmental samples after one day (p < .001). The greatest reduction was seen on soft surfaces (like notoriously hard-to-clean privacy curtains) where DHP demonstrated a 99.5% reduction after one day. Explore more results from this extensive study below.
Effectiveness of DHP on Reducing Environmental Microbial Bioburden Risk in a Pediatric Oncology Intensive Care Unit
By analyzing surface samples from rooms in the intensive care unit before and after DHP was deployed, this study demonstrates that the overall mean surface microbial burden was significantly reduced.
Simply put, DHP was proven effective and improved the quality of environmental cleaning. Read more about the results.
Dry Hydrogen Peroxide: A Novel Solution for Reducing Microbial Bioburden in Healthcare
Healthcare-associated infections (HAIs), and now COVID-19, place a huge burden on the U.S. healthcare system and the patients it serves. Research has revealed that even after manual cleaning, as many as 50% of surfaces remain contaminated with pathogens, including multi-drug resistant organisms (MDROs).5
Now, an innovative technology has emerged to support the efforts expended on environmental cleaning and disinfection—Synexis and its unique DHP Technology. Read about reducing microbial bioburden in the healthcare setting below.
DHP Technology for Reduction of Microbial Colonization in the Hospital Setting
In this study, DHP was incorporated into a community hospital’s 34-bed Cardiovascular/Telemetry unit’s existing HVAC system. The study was designed to answer the question: Does DHP reduce microbial contamination in the hospital unit?
The results showed a significant reduction in microbes over seven days. Dig into the details below.
Spread the Word
Read our brochure, pass it around, and share how Synexis can help make your healthcare facility a cleaner place.
1. Arnold C. “Rethinking sterile: the hospital microbiome,” Environmental Health Perspectives, 2014.
2. Stone P. W. “Economic burden of healthcare-associated infections: an American perspective,” Expert Rev Pharmacoecon Outcomes Res, 2009.
3. “Hydrogen Peroxide,” Occupational Safety and Health Administration, 2018, www.osha.gov/chemicaldata/chemResult.html?recNo=630
4. Sanguinet J, Edminston C. Evaluation of Dry Hydrogen Peroxide in Reducing Microbial Bioburden in a Healthcare Facility. American Journal of Infection Control. 2021 Mar; DOI: https://doi.org/10.1016/j.ajic.2021.03.004
5. Chemaly RF, Simmons S, Dale C et al. The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment. Ther Adv Infect Dis. 2014 Jun;2(3- 4):79-90. https://www.ncbi.nlm.nih.gov/pubmed/25469234